![Hannover Rück SE Website](https://cdn.finchat.io/882255.png)
Hannover Rück SE
XTRA-HNR1
Company Overview
Hannover Rück SE, together with its subsidiaries, provides reinsurance products and services worldwide. It operates through Property & Casualty Reinsurance, and Life & Health Reinsurance segments. The company offers property, casualty, facultative, catastrophe XL, structured reinsurance, and insurance-linked securities. It also provides risk solutions for agricultural, livestock, and bloodstock businesses; aviation and space business; and marine and offshore energy business, as well as credit, surety, and political risks reinsurance products. In addition, the company offers group and individual credit life, enhanced annuities, group life and health, and Takaful reinsurance products; and risk solutions in the areas of critical illness, disability, health, longevity, long term care, mortality, and morbidity. Further, it provides various financial solutions, including new-business financing; monetization of embedded value; reserve and solvency relief; and divestiture of non-core businesses. The company was formerly known as Hannover Rückversicherung AG and changed its name to Hannover Rück SE in March 2013. The company was founded in 1966 and is headquartered in Hanover, Germany. Hannover Rück SE is a subsidiary of Talanx AG.
Name
Hannover Rück SE
CEO
Mr. Jean-Jacques Henchoz
Website
www.hannover-re.com
Sector
Insurance
Year Founded
1966
Profile
Market Cap
€30.98B
EV
€35.64B
Shares Out
120.6M
Revenue
€25.71B
Employees
3,856
Margins
Gross
10.12%
EBITDA
8.35%
Operating
8.03%
Pre-Tax
8.44%
Net
7.88%
FCF
22.14%
Returns (5Yr Avg)
ROA
1.7%
ROTA
14.47%
ROE
11.26%
ROCE
3.94%
ROIC
2.1%
Valuation (TTM)
P/E
—
P/B
—
EV/Sales
—
EV/EBITDA
—
P/FCF
—
EV/Gross Profit
—
Valuation (NTM)
Price Target
€247.33
P/E
—
PEG
—
EV/Sales
—
EV/EBITDA
—
P/FCF
—
Financial Health
Cash
€1,068.6M
Net Debt
€3,823.5M
Debt/Equity
0.43
EBIT/Interest
14.23
Growth (CAGR)
Rev 3Yr
1.78%
Rev 5Yr
5.07%
Rev 10Yr
6.7%
Dil EPS 3Yr
20.77%
Dil EPS 5Yr
11.66%
Dil EPS 10Yr
8.26%
Rev Fwd 2Yr
6.36%
EBITDA Fwd 2Yr
—
EPS Fwd 2Yr
16.05%
EPS LT Growth Est
12.32%
Dividends
Yield
—
Payout
35.72%
DPS
€6
DPS Growth 3Yr
10.06%
DPS Growth 5Yr
9.86%
DPS Growth 10Yr
7.18%
DPS Growth Fwd 2Yr
13.55%